Ginkgo Bioworks Holdings, Inc. Investors: Company Investigated by the Portnoy Law Firm LOS ANGELES, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ginkgo Bioworks Holdings, Inc. ("Ginkgo" or the "Company") (NYSE: DNA) investors that the firm has initiated an...

Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies - Combining both companies’ cell therapy leadership and expertise, the collaboration covers the research and development of “off-the-shelf” cell therapies for up to five shared cancer targets and the...